Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA
05/04/2024 12:52
April 5 (Reuters) - IntelGenx Technologies Corp
IGX.TO :
* INTELGENX UPDATES STATUS OF BUPRENORPHINE BUCCAL FILM ANDA
* INTELGENX TECHNOLOGIES CORP: CHEMO RESEARCH SL GOT CRL
FROM FDA
ON RESUBMITTED ABBREVIATED NEW DRUG APPLICATION FOR
BUPRENORPHINE BUCCAL FILM
* INTELGENX: FDA CONFIRMED NO ADDITIONAL INSPECTION OF CO'S
FACILITY IS REQUIRED AT THIS TIME
* INTELGENX TECHNOLOGIES CORP: CRL INCLUDES A REQUEST FOR
ADDITIONAL PHARMACEUTICAL QUALITY INFORMATION
Source text for Eikon: ID:nGNXbvbV1L
Further company coverage: IGX.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Intelgenx Technologies
See all newsBrief: Intelgenx Obtains Court-Approval Of Sale & Investment Solicitation Process
Brief: Intelgenx Initiates Restructuring Proceedings Under CCAA To Implement Review Of Its Strategic Alternatives
Brief: Intelgenx Initiates Restructuring Proceedings Under The CCAA
Brief: IntelGenx Says First Parkinson’s Disease Patients Dosed With Montelukast VersaFilm in Mid-Stage Clinical Trial
Brief: IntelGenx Updates Status Of Buprenorphine Buccal Film ANDA